CNS Pharmaceuticals Inc Net Asset Quality Index
CNS Pharmaceuticals Inc net asset quality index. CNS Pharmaceuticals Inc (CNSP) has a Net Asset Quality Index of 83.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $21.94 Million minus total liabilities of $3.74 Million yields net assets of $18.20 Million. A higher index indicates a stronger, lower-leverage balance sheet. Explore how well can CNS Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of CNS Pharmaceuticals Inc (2017–2025)
Net asset quality index of CNS Pharmaceuticals Inc from 2017 to 2025. This chart shows how CNS Pharmaceuticals Inc's Net Asset Quality Index has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the index stands at 83.0%, representing net assets of $18.20 Million against total assets of $21.94 Million USD. See CNS Pharmaceuticals Inc (CNSP) shareholders funds for net asset value and shareholders' equity analysis.
CNS Pharmaceuticals Inc Net Asset Quality Index by Year (2017–2025)
CNS Pharmaceuticals Inc net asset quality index by year from 2017 to 2025. The table below presents the year-by-year Net Asset Quality Index for CNS Pharmaceuticals Inc from 2017 to 2025, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CNS Pharmaceuticals Inc stock valuation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 52.4% | $4.52 Million | $8.62 Million | $4.10 Million | ▼ -18.5 pp |
| 2024 | 71.0% | $6.18 Million | $8.70 Million | $2.52 Million | ▲ +331.6 pp |
| 2023 | -260.6% | $-4.43 Million | $1.70 Million | $6.13 Million | ▼ -322.9 pp |
| 2022 | 62.3% | $8.13 Million | $13.05 Million | $4.92 Million | ▼ -13.3 pp |
| 2021 | 75.6% | $6.62 Million | $8.76 Million | $2.14 Million | ▼ -12.4 pp |
| 2020 | 88.0% | $13.95 Million | $15.85 Million | $1.91 Million | ▼ -8.1 pp |
| 2019 | 96.1% | $7.60 Million | $7.91 Million | $311.00K | ▲ +176.5 pp |
| 2018 | -80.4% | $-549.30K | $683.33K | $1.23 Million | ▼ -44.3 pp |
| 2017 | -36.1% | $-58.53K | $162.19K | $220.73K | — |